[1]
Wahab, S.A. and et al. 2020. GMP manufacture of Regulatory T cells (Tregs) to facilitated reduced reliance on immunosuppressive drugs following renal transplantation. Journal of the Nuffield Department of Surgical Sciences. 1, 2 (Feb. 2020).